← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2004First marketed drug
Oct 28, 1996First NDA
Oct 28, 1996Last known activity
Mar 1, 2016
Acquired by GlaxoSmithKline on Jan 1, 2009
Timeline
1840s
- Jan 1, 1847
Stiefel Laboratories— Founded
1990s
- Oct 28, 1996
acitretin— NDA Organization
2000s
- Aug 26, 2002
clindamycin— NDA Secondary Org
- Aug 26, 2002
clindamycin— Marketing Organization
- Jan 1, 2006
Connetics— Acquired
- Jan 1, 2008
Barrier Therapeutics— Acquired
- Jan 1, 2009
GlaxoSmithKline— Acquired By
Drugs by trial phase (28 distinct, 54 trials)
Phase 4 (11 own, 1 via acquisition)
Phase 3 (7 own, 0 via acquisition)
Phase 2 (3 own, 1 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Indications
Approved for
Marketed drugs (5)
Subsidiaries (2 direct, 4 total across the full acquisition tree)
Recent trials (50)
- NCT02673619Lead sponsorPhase 2Mar 1, 2016
- NCT02411162Lead sponsorPhase 1Jul 7, 2015
- NCT02014584Lead sponsorPhase 3Jul 1, 2014
- NCT01984775Lead sponsorPhase 1Oct 30, 2013
- NCT01245140Lead sponsorPhase 2Apr 1, 2011
- NCT01323673Lead sponsorPhase 4Nov 1, 2010
- NCT01119651Lead sponsorPhase 1Jun 14, 2010
- NCT01132443Lead sponsorPhase 1May 6, 2010
- NCT01139580Lead sponsorPhase 3May 1, 2010
- NCT01115322Lead sponsorPhase 1Apr 1, 2010
- NCT01114841Lead sponsorPhase 1Mar 31, 2010
- NCT01112787Lead sponsorPhase 1Mar 26, 2010
- NCT01039883Lead sponsorPhase 1Nov 23, 2009
- NCT01019603Lead sponsorPhase 1Oct 12, 2009
- NCT00832364Lead sponsorPhase 4Oct 1, 2009
Details
- Founded
- Offenbach-am-Main, DE Jan 1, 1847
- First NDA
- Oct 28, 1996
- Last known activity
- Mar 1, 2016
Notes
Acquired by GlaxoSmithKline